英文字典中文字典


英文字典中文字典51ZiDian.com



中文字典辞典   英文字典 a   b   c   d   e   f   g   h   i   j   k   l   m   n   o   p   q   r   s   t   u   v   w   x   y   z       







请输入英文单字,中文词皆可:

eikon    
n. 圣像;画像;肖像;插画;图

圣像;画像;肖像;插画;图


请选择你想看的字典辞典:
单词字典翻译
Eikon查看 Eikon 在百度字典中的解释百度英翻中〔查看〕
Eikon查看 Eikon 在Google字典中的解释Google英翻中〔查看〕
Eikon查看 Eikon 在Yahoo字典中的解释Yahoo英翻中〔查看〕





安装中文字典英文字典查询工具!


中文字典英文字典工具:
选择颜色:
输入中英文单字

































































英文字典中文字典相关资料:


  • Refinitiv Eikon
    All the information you need to install and to download Refinitiv Eikon Direct link to test if your system can run Refinitiv Eikon
  • Eikon Therapeutics
    Eikon is a late-stage clinical biopharmaceutical company advancing a pipeline of potential therapies for patients with unmet medical needs We are passionate about novel therapeutics and share the belief that a better understanding of fundamental human disease biology can lead to better medicines
  • Eikon Therapeutics Announces Fourth Quarter and Full Year 2025 . . .
    Eikon Therapeutics Announces Fourth Quarter and Full Year 2025 Financial Results and Provides Clinical and Corporate Updates PRESS RELEASE GlobeNewswire Mar 30, 2026, 07:48 AM
  • EIKON – Delivering quality and precision at scale
    EIKON is a global leader in content mastering, localization, and distribution We work with the world’s biggest studios and streaming platforms – guaranteeing quality and precision across all projects, large or small
  • Eikon Therapeutics Completes Upsized IPO Raising $381 Million and . . .
    Eikon Therapeutics, Inc recently announced its fourth quarter and full year 2025 financial results, highlighting significant progress in its clinical programs and a successful upsized initial public offering that raised $381 million in February 2026
  • Eikon Therapeutics Reports 2025 Financial Results, Upsized IPO, and Key . . .
    Eikon Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results: Key Corporate and Clinical Developments IPO Success and Strengthened Financial Position Eikon Therapeutics, Inc (Nasdaq: EIKN), a late-stage clinical biopharmaceutical company focused on developing innovative cancer therapies, announced significant milestones in its fourth-quarter and full-year 2025 results Most
  • Eikon upsized $381M listing marks largest biotech IPO since 2024
    At $381 million, Eikon looks set to be the largest biotech IPO since 2024, overtaking Aktis Oncology’s $318 million offering last month The California-based company has already set out its plans
  • Eikon Therapeutics Announces Fourth Quarter and Full Year 2025 . . .
    Eikon is a late-stage clinical biopharmaceutical company dedicated to building a global, fully-integrated organization developing innovative medicines to address serious unmet medical needs
  • Eikon Withdrawal and Transition to Workspace | Data Analytics
    As part of our ongoing evolution, Eikon was withdrawn from LSEG’s product line on 30th June 2025 You can now supercharge your impact with our flagship data and analytics workflow solution, LSEG Workspace
  • Eikon Therapeutics (EIKN) Stock Price Overview
    A detailed overview of Eikon Therapeutics, Inc (EIKN) stock, including real-time price, chart, key statistics, news, and more





中文字典-英文字典  2005-2009